
ScreenPoint was founded in 2014 as a spin-off from Radboud University Medical Center in Nijmegen, The Netherlands, to develop and bring to the market innovative machine learning solutions to improve breast cancer screening and diagnosis. With an exceptional team of specialists in machine learning, image analysis, and breast imaging, ScreenPoint developed the market leading AI solution Transpara for reading mammograms and breast tomosynthesis. Clinical studies demonstrate that the FDA cleared sof
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account